MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced that it has closed the previously disclosed acquisition of the outstanding shares of SenoRx, Inc. With the transaction completed, the SenoRx organization is now part of Bard’s Peripheral Vascular division.
